Category: Defiance ETFs

Investing vs Consuming

On June 22, 2012 Tesla released their Model S electric car, at the price of $77,400 for the 300-mile version. If you had purchased the car, you would now own a Tesla Model S at its depreciated value. If you had used the same sum of money to buy Tesla stock, which was valued at a split adjusted price of $6.52,1 you would now own 11,809 shares, each valued at $695. Your $77,400 would now b...

Read More
Category: SPAK

SPAC as the new private equity?

BlackRock CEO Larry Fink has highlighted some significant shifts in asset management behavior. As head of the world’s largest asset manager, with $7.4 trillion under its purview, Fink’s comments carry significant weight. 1 He has pointed to the “tsunami of change in asset reallocation right now,” and that SPACs could come to replace the traditional private equity model of buyouts. 2 So h...

Read More
Category: SPAK

Defiance ETFs Case Study for DraftKings: Making Sports Betting Mainstream

Special Purpose Acquisition Companies (SPACs) are bespoke tools that allow a fledgling company to become public without the traditional IPO process. SPACs are companies that IPO with the explicit goal of executing an acquisition or merger with a private company. The SPAC itself has no operations and is sometimes called a “blank check” company, as its shareholders essentially entrust thei...

Read More
Category: SPAK

Defiance ETFs Case Study for Virgin Galactic: Virgin Galactic Shows SPACs Can Spot Potential

Richard Branson formed the space tourism company, Virgin Galactic in 2004. The company’s aim is to produce reusable space vehicles, to make space travel accessible for (wealthy) private individuals and scientists. While its first 6-person, 90-minute flight was scheduled for 2020 but delayed due to the impact of Covid-19 restrictions, Virgin Galactic envisions “flight opportunities for bo...

Read More
Category: IBBJ

The Launch of Nasdaq Junior Biotech

The Nasdaq Junior Biotechnology Index (NBIJR) was launched on April 30, 2020, in the midst of the Coronavirus pandemic, perhaps the most consequential backdrop imaginable for the overall Biotech industry. NBIJR’s methodology is rather straightforward, taking the existing membership of the Nasdaq Biotechnology Index (NBI) and limiting constituents by placing a cap on market capitalization...

Read More
Category: IBBJ

Defiance ETFs Rings The Nasdaq Closing Bell

Defiance ETFs, a thematic ETF company built for the next generation of investors, rang the Nasdaq Closing Bell remotely from across the country. Paul Dellaquila, President, rang the Closing Bell in a virtual bell ringing ceremony. View the original video at Nasdaq.com 

Read More

Want to work with us?

A wonderful serenity has taken possession of my entire soul, like these sweet mornings of spring which I enjoy with my whole heart. I am alone, and feel the charm of existence in this spot.

Contact us